Chapter 5
Health Care and HIV/AIDS

Chapter 1

Pathogenesis
Types of HIV
Modes of Transmission
Risk Factors for Women

Chapter 2

Epidemiology
Women and AIDS
Adolescents and HIV/AIDS
HIV/AIDS Among African- 
  Americans and Hispanics
HIV/AIDS Exposure

Chapter 3

Tuberculosis & HIV Infection
Pneumocystis Carinii Pneumonia
Other Common Diseases

Chapter 4

Counseling and Testing
  Goals for Counseling and Testing
  Objectives
  Necessary Elements
  Important Definitions
  Risk Assessment
  What Else to Discuss

Guidelines for Informing Patient of Results
  Negative Results
  Positive HIV Test Results
  Interpretation of HIV-Antibody
    Test Results
  Partner Notification/Contact Tracing

Chapter 5

Health Care and HIV/AIDS
Preventive Strategies

Recommendations
Universal Precautions
  Use of Protective Barriers
 
Needle and sharps disposal
  Hand washing
 
Cleaning and decontaminating
     spills of blood
 
Laundry
  Decontamination and
    Laundering of Protective Clothing
  Infective Waste

Chapter 6

Strategies for Preventing Disease
Practice Safe Sex
Seek Treatment Early If Infected
  with an STD
Do Not Share Injection Drug Use
  Equipment

Chapter 7

Overview of Florida Law and HIV/AIDS
  Testing
  Confidentiality
  Treatment of Patients
Changes in reporting HIV made
  by Legislature
HIV/AIDS Education

Test Questions

Final Exam/Evaluation

Florida Laws (power point)

Main Page
 

Of the adults reported with AIDS in the United States through to December 31, 2001, 23,951 had been employed in health care representing 5.1% of the 469,850 AIDS cases reported to the CDC for whom occupational information was known.  (CDC, Surveillance of Healthcare Personnel, 2001).

Healthcare workers whose practices are modified because of their HIV infection status should, whenever possible, be provided opportunities to continue appropriate patient-care activities.  Career counseling and job retraining should be encouraged to promote the continued use of their talents, knowledge and skills.

Health care workers during the course of providing care can also find themselves at significant risk for exposure to HIV transmission.  The average risk of transmission of HIV is approximately 0.3 % (95% CI 0.2-0.5%) after a percutaneous or needlestick exposure and approximately 0.09% (95% CI 0.006-0.5%) after a mucous membrane exposure (MMWR  2001;50 RR-11). The risks from non-intact skin exposure and exposure to body fluids other than blood are felt to be considerably less.

Preventive Strategies and Infection Control

 

Recommendations for the prevention of transmission of HIV in healthcare settings have been made by the CDC that emphasize adherence to standard precautions.  Standard precautions are intended to prevent parenteral, mucous membrane, and non-intact skin exposures of health care workers to blood-borne pathogens. They apply to blood and other fluids containing visible blood as blood is the single most important source of HIV and other blood-borne pathogens in the occupational setting.  Healthcare personnel should follow infection control precautions at all times. 

 

These precautions include:

 

bulletthe routine use of barriers such as gloves, gowns, masks, or goggles when anticipating contact with blood or body fluids with visible blood
bulletwashing hands and other skin surfaces immediately after contact with blood or body fluids, and
bulletthe careful handling and disposal of sharp instruments during and after use

 

Body fluids considered to be potentially infectious include cerebrospinal, synovial, pleural, peritoneal, pericardial and amniotic fluids.  Semen and vaginal secretions have been implicated in sexual transmission of HIV but not in occupational transmission. 

Feces, nasal secretions, saliva, sputum, sweat, tears, urine, and vomitus are not considered potentially infectious unless they contain blood.  In situations such as emergencies wherein differentiation between fluid types is difficult, if not impossible, all body fluids should be treated as potentially infectious.

 

Hands and other skin surfaces should be washed immediately and thoroughly with soap and water if contaminated with blood, other body fluids, or potentially contaminated articles.  Use alcohol based antiseptic hand cleanser or wash hands after removing gloves and with each patient contact.

 

Safety devices have been developed to help prevent needlestick injuries. Needles should not be recapped, purposely bent or broken by hand, removed from disposable syringes or otherwise manipulated by hand.  If recapping is necessary, use a one-handed technique or recapping block device.

 

Institutions should provide all healthcare personnel with appropriate in-service or education regarding infection control and safety and should establish procedures for monitoring compliance with infection-control policies.

 

Management of Occupational Exposure to HIV

 

If a healthcare worker is exposed to potentially infected blood or body fluids, the wound should be immediately washed or the mucous membrane flushed.  Reporting and evaluation of potential exposure to HIV should be done within hours as initiation of post-exposure prophylaxis (PEP) is felt to be most effective is administered in the first 24-36 hours after exposure.  The healthcare personnel should be tested for HIV at baseline.

 

Percutaneous exposure to larger quantity of blood or visibly bloody fluid, or instruments that have been placed directly in a vein or artery, or resulting in deep injuries confer higher risk.  The source patient for the exposure should also be assessed when able.  HIV infected sources in the terminal stage of their illness likely have higher viral load and risk for transmission.

 

When the HIV status of the source is unknown, determine the presence of risk factors or the presence of findings that make HIV likely.  Test the source whenever possible using rapid HIV tests.  If the source is unknown, consider PEP in settings where exposure to HIV-infected persons is likely such as drug treatment facilities or STD centers.

 

PEP with either a 2- or 3-drug antiretroviral regimen as outlined in the CDC recommendations (MMWR  2001;50 RR-11) is to be given for 28 days.  The HCW is counseled on the potential side and monitored for drug toxicity.  Perform HIV antibody testing at 6 weeks, 3 months and 6 months after exposure.

 

Risk for hepatitis B and C exposure should also be assessed and addressed.

 

Next -- Chapter 6>>

Main |   Chapter 1 | Chapter 2 | Chapter 3 | Chapter 4 | Chapter 5 | Chapter 6 | Chapter 7
Test Questions | Final Test/Evaluation |
MECOP Home